Conventional DMARDs are used as monotherapy or in combination and include methotrexate, leflunomide, azathioprine, ciclosporin, hydroxychloroquine, sulfasalazine, gold and minocycline. Biologic ...

That's mostly due to two types of prescriptions, disease-modifying antirheumatic drugs or DMARDs and biologics. Conventional DMARDs including pills like methotrexate and hydroxychloroquine ...

The names of different classes of biologic DMARDs refer to the specific cytokine or cell type they target. These include: People can take DMARDs by mouth or as injections. Doses may range from ...

Biologic disease-modifying antirheumatic drugs (DMARDs) such as adalimumab, etanercept and infliximab are effective at reducing symptoms and slowing progression of rheumatoid arthritis (RA).

Biologic agents are the mainstay of treatment for RA as they can induce disease remission. The use of nonbiologic DMARDs, especially leflunomide, declined rapidly after the introduction of tumor ...

Medically reviewed by Mary Choy, PharmDJoint pain can be caused by a number of biological, psychological, and social factors.

Use of conventional synthetic drugs to treat juvenile idiopathic arthritis (JIA) fell by half during 2000-2022, as targeted ...

In recent years, there's been a revolution in Disease-Modifying Antirheumatic Drugs, known as DMARDs, available to control RA, driven largely by biologic therapies. What are these agents ...

As more innovative therapies, especially biologics and DMARDs, become available, patients will benefit from improved quality of life and disease management. However, challenges such as high ...

New research reveals that starting with a combination of three traditional disease-modifying antirheumatic drugs (called DMARDs) for treating early rheumatoid arthritis is more cost-effective long ...